GTR 91415888
Tenders Are Invited For Pharmaceutical Products – Antitumor And Endocrinological Substances (L01-L02)
ICB — International Competitive Bid
Closed
Northern Europe
Tender Information
GTR Reference
91415888
Tendering Authority
Subscribe to view
Tender No
38044-2025
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Antitumor And Endocrinological Substances (L01-L02)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Northern Europe
Political Region
European Union
Last Date of Bid Submission
17-02-2025
Closed
Work Detail
Pharmaceutical Products – Antitumor And Endocrinological Substances (L01-L02). Cyclophosphamide,Ifosfamide,Temosolomiid,Methotrexate,Pemetrekseed,Fluorouratsiil,To Gemcitabine,Capecitabine,To Vinorelb,Etoposide, Concentrate For Solution For Infusion, 100Mg-200Mg In A Vial,Etoposide, Soft Capsule, 100Mg,Paclitaxel,Docetaxel,To Doxorubicin,Epirubicin,Mitomycin,Pertuzumab,Trastuzumab-Emtansine,Trastuzumab-Deruxtecan,Nivolumab, Concentrate For Solution For Infusion, 40Mg/4Ml,Nivolumab, Concentrate For Infusion Solution, 100Mg/10Ml,Nivolumab, Concentrate For Solution For Infusion, 240Mg/24Ml,Pembrolizumab,Durvalumab,Atesolizumab,Dostarlimab,Non-Platinum,Karboplatiin,Oxaliplatin,Estramustine,Of Course,Irinoteka,Lets Measure,To Eribuli,Pertuzumab + Trastuzumab,To Goserel,Fulvestrant,Belimumab, Solution For Injection In A Syringe Or Pen-Syringe, 200Mg,Belimumab, Powder For Concentrate For Infusion, 120Mg And 400Mg
Key Value
Tender Value
12,398,000 - EEK
Tender Documents
Global Tender Document
2a6f221b-3a1f-47f1-9a5d-15fbc017ecc1.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.